Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) COO Kristen Oelschlager sold 8,586 shares of the stock in a transaction dated Monday, August 3rd. Get Castle Biosciences alerts:Castle Biosciences (NASDAQ:CSTL – Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. BTIG raises Castle Biosciences price targetThe revised target indicates substantial potential upside and reflects confidence in Castle Biosciences’ diagnostic-testing growth outlook. Castle Biosciences diagnostics updateRecent coverage highlighted developments involving Castle Biosciences’ diagnostics business, but the available details do not indicate whether the update will materially affect revenue, earnings or reimbursement expectations. Read MoreReceive News & Ratings for Castle Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castle Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.